Top Banner
Global H1N1 Vaccines Market 2014- 2018 TechNavio Insights
9

Global H1N1 Vaccines Market 2014-2018

Nov 03, 2014

Download

Healthcare

TechNavio

H1N1 influenza (zoonotic) is an infectious disease in humans caused by a variant of the swine H1N1 virus, known as H1N1v virus. The H1N1v virus is a contagious virus which infects nose, throat, and lungs. H1N1 virus is an RNA virus belonging to the Orthomyxoviridae family.TechNavio's analysts forecast the Global H1N1 Vaccines market to grow at a CAGR of 5.40 percent over the period 2013-2018.
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Global H1N1 Vaccines Market 2014-2018

Global H1N1 Vaccines Market 2014-2018

TechNavio Insights

Page 2: Global H1N1 Vaccines Market 2014-2018

USA – CANADA – UK – CHINA – INDIA

Market Overview: H1N1 Vaccines

About H1N1 Vaccines• H1N1 influenza (zoonotic) is an infectious disease in humans caused by a variant of the swine H1N1 virus, known as H1N1v

virus.

• The H1N1v virus is a contagious virus which infects nose, throat, and lungs. H1N1 virus is an RNA virus belonging to the Orthomyxoviridae family.

• Influenza A viruses infect different animal species such as humans, swine, birds, seals, and horses.

• Influenza A viruses can be subdivided on the basis of antigenicity of its surface glycoproteins neuraminidase and hemagglutinin. Hemagglutinin component is used by the virus to bind to host cell receptors.

• Elderly people, young children, and people with medical conditions including liver disorders, blood disorders, kidney disorders, chronic lung disease, asthma, and neurodevelopmental and neurological conditions are at a higher risk of getting infected.

• Vaccination of high-risk groups prevents unnecessary hospitalizations and premature deaths resulting due to influenza.

• TechNavio's analysts forecast the Global H1N1 Vaccines market to grow at a CAGR of 5.40 percent over the period 2013-2018.

Page 3: Global H1N1 Vaccines Market 2014-2018

USA – CANADA – UK – CHINA – INDIA

Covered in This Report

• This report covers the present scenario and the growth prospects of the Global H1N1 Vaccines market for the period 2014-2018.

• To calculate the market size, the report considers the revenue generated through the sales of various vaccines administered to prevent human infection caused by H1N1 virus.

• TechNavio's report, the Global H1N1 Vaccines Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts.

• The report covers the Americas, and the EMEA and APAC regions; it also covers the Global H1N1 Vaccines market landscape and its growth prospects in the coming years.

• The report also includes a discussion of the key vendors operating in this market.

Page 4: Global H1N1 Vaccines Market 2014-2018

USA – CANADA – UK – CHINA – INDIA

Key Regions

Americas

EMEA

APAC

Page 5: Global H1N1 Vaccines Market 2014-2018

USA – CANADA – UK – CHINA – INDIA

Key Vendors

Key Vendors• AstraZeneca• GlaxoSmithKline• Novartis• Sanofi Pasteur

Other Prominent Vendors• Baxter International• bioCSL• Mitsubishi Tanabe Pharma• Protein Sciences Corporation• Serum Institute of India• Sinovac Biotech• Zydus Cadila

Page 6: Global H1N1 Vaccines Market 2014-2018

USA – CANADA – UK – CHINA – INDIA

Market Drivers, Challenges and Trends

Guest BloggersDriver• Increased Awareness on H1N1 Influenza.• For a full, detailed list, view our report.

Challenge• Antigenic Drift of H1N1v Virus.• For a full, detailed list, view our report.

Trend• Emergence of Quadrivalent Vaccines.• For a full, detailed list, view our report.

A detailed analysis of each market driver, challenge and trend is available

in our report:

Global H1N1 Vaccines Market 2014-2018

Page 7: Global H1N1 Vaccines Market 2014-2018

USA – CANADA – UK – CHINA – INDIA

Key Questions

Questions Answered in Our Report• What will the market size be in 2018 and what will the growth rate be?• What are the key market trends?• What is driving this market?• What are the challenges to market growth?• Who are the key vendors in this market space?• What are the market opportunities and threats faced by the key

vendors?• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

Page 8: Global H1N1 Vaccines Market 2014-2018

USA – CANADA – UK – CHINA – INDIA

View Our Report

Global H1N1 Vaccines Market 2014-2018

View Report >>

TechNavio's report, Global H1N1 Vaccines Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts.

Published on: October 01, 2014 | 65 Pages | SKU: IRTNTR4221

Page 9: Global H1N1 Vaccines Market 2014-2018

USA – CANADA – UK – CHINA – INDIA

Access the Report

USA – CANADA – UK – CHINA – INDIA

India: An Overview

USA – CANADA – UK – CHINA – INDIA

About Us

USA – CANADA – UK – CHINA – INDIA

Thank You!

North America

Chicago, USA

Phone: +1 630 333 9501  

Fax: +1 630 833 2171

Europe

London, United Kingdom

Phone: +44 208 123 1770

Fax: +44 845 280 2825

Asia

Bangalore, India

Phone: +91 934 254 0560

Fax: +91 80 4080 6070

Mail us at: [email protected]

You can visit us at:www.technavio.com

DISCLAIMER

This presentation is intended solely for showcasing Infiniti’s research capabilities. All information contained within this presentation has been randomized and should not be used for any kind of analysis and/or for decision making purpose. All trademarks and copyrights remain the sole ownership of their rightful owners/licensees. In no event shall Infiniti Research have any liability to any party for special, incidental, tort, or consequential damages arising out of

or in connection with this report, even if Infiniti Research has been advised of the possibility of such damages.

Copyright ©2013 Infiniti Research Limited. All Rights Reserved.

Reproduction without written permission is completely forbidden.

NOT FOR FURTHER DISTRIBUTION